BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33007936)

  • 1. Role of Viral Ribonucleoproteins in Human Papillomavirus Type 16 Gene Expression.
    Kajitani N; Schwartz S
    Viruses; 2020 Sep; 12(10):. PubMed ID: 33007936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.
    Wu C; Kajitani N; Schwartz S
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of human papillomavirus gene expression by splicing and polyadenylation.
    Johansson C; Schwartz S
    Nat Rev Microbiol; 2013 Apr; 11(4):239-51. PubMed ID: 23474685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of human papillomavirus gene expression by alternative splicing.
    Graham SV; Faizo AAA
    Virus Res; 2017 Mar; 231():83-95. PubMed ID: 27867028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus regulation of SR proteins.
    McFarlane M; Graham SV
    Biochem Soc Trans; 2010 Aug; 38(4):1116-21. PubMed ID: 20659014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillomavirus transcripts and posttranscriptional regulation.
    Schwartz S
    Virology; 2013 Oct; 445(1-2):187-96. PubMed ID: 23706315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner.
    Kajitani N; Glahder J; Wu C; Yu H; Nilsson K; Schwartz S
    Nucleic Acids Res; 2017 Sep; 45(16):9654-9678. PubMed ID: 28934469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-16 RNA processing.
    Schwartz S
    Front Biosci; 2008 May; 13():5880-91. PubMed ID: 18508629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
    Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the DNA Damage Response in Human Papillomavirus RNA Splicing and Polyadenylation.
    Nilsson K; Wu C; Schwartz S
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632.
    Somberg M; Zhao X; Fröhlich M; Evander M; Schwartz S
    J Virol; 2008 Apr; 82(7):3665-78. PubMed ID: 18216120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of heterogenous nuclear ribonucleoproteins (hnRNPs) and serine- and arginine-rich (SR) proteins that induce human papillomavirus type 16 late gene expression and alter L1 mRNA splicing.
    Hao C; Gong L; Cui X; Jönsson J; Zheng Y; Wu C; Kajitani N; Schwartz S
    Arch Virol; 2022 Feb; 167(2):563-570. PubMed ID: 34860285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA Binding Proteins that Control Human Papillomavirus Gene Expression.
    Kajitani N; Schwartz S
    Biomolecules; 2015 May; 5(2):758-74. PubMed ID: 25950509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA elements that control human papillomavirus mRNA splicing-targets for therapy?
    Schwartz S; Wu C; Kajitani N
    J Med Virol; 2024 Feb; 96(2):e29473. PubMed ID: 38362929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.
    Li X; Johansson C; Glahder J; Mossberg AK; Schwartz S
    Nucleic Acids Res; 2013 Dec; 41(22):10488-508. PubMed ID: 24013563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation.
    Yu L; Majerciak V; Zheng ZM
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.
    Rush M; Zhao X; Schwartz S
    J Virol; 2005 Sep; 79(18):12002-15. PubMed ID: 16140776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.
    Zhao X; Rush M; Schwartz S
    J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV and RNA Binding Proteins: What We Know and What Remains to Be Discovered.
    Graham SV
    Viruses; 2024 May; 16(5):. PubMed ID: 38793664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.